Fibroblast growth factor 19 entry into brain

Fluids and Barriers of the CNS

Volumn 10, Issue 1, 2013, Pages

  Hsuchou, Hung ^a   Pan, Weihong ^a   Kastin, Abba J ^a  

^a PENNINGTON BIOMEDICAL RESEARCH CENTER   (United States)

Author keywords

Blood brain barrier; FGF15; FGF19; Kidney; Liver

Indexed keywords

FIBROBLAST GROWTH FACTOR 19; IODINE 125;

ANIMAL EXPERIMENT; ARTICLE; BLOOD BRAIN BARRIER; BRAIN HOMOGENATE; BRAIN PERFUSION; HALF LIFE TIME; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; KIDNEY CLEARANCE; KIDNEY TUBULE ABSORPTION; MALE; METABOLIC CLEARANCE RATE; MOUSE; NONHUMAN; PRIORITY JOURNAL;

EID: 84887075902     PISSN: None     EISSN: 20458118     Source Type: Journal    
DOI: 10.1186/2045-8118-10-32     Document Type: Article

References (29)

1. Fukumoto S. Actions and mode of actions of FGF19 subfamily members. Endocr J 2008, 55:23-31. 10.1507/endocrj.KR07E-002, 17878606.
2. Jones S. Mini-review: endocrine actions of fibroblast growth factor 19. Mol Pharm 2008, 5:42-48. 10.1021/mp700105z, 18179175.
3. Tomlinson E, Fu L, John L, Hultgren B, Huang X, Renz M, Stephan JP, Tsai SP, Powell-Braxton L, French D, Stewart TA. Transgenic mice expressing human fibroblast growth factor-19 display increased metabolic rate and decreased adiposity. Endocrinology 2002, 143:1741-1747. 10.1210/en.143.5.1741, 11956156.
4. Fu L, John LM, Adams SH, Yu XX, Tomlinson E, Renz M, Williams PM, Soriano R, Corpuz R, Moffat B, Vandlen R, Simmons L, Foster J, Stephan JP, Tsai SP, Stewart TA. Fibroblast growth factor 19 increases metabolic rate and reverses dietary and leptin-deficient diabetes. Endocrinology 2004, 145:2594-2603. 10.1210/en.2003-1671, 14976145.
5. McWhirter JR, Goulding M, Weiner JA, Chun J, Murre C. A novel fibroblast growth factor gene expressed in the developing nervous system is a downstream target of the chimeric homeodomain oncoprotein E2A-Pbx1. Development 1997, 124:3221-3232.
6. Ryan KK, Kohli R, Gutierrez-Aguilar R, Gaitonde SG, Woods SC, Seeley RJ. Fibroblast growth factor-19 action in the brain reduces food intake and body weight and improves glucose tolerance in male rats. Endocrinology 2013, 154:9-15. 10.1210/en.2012-1891, 23183168.
7. Miyake A, Itoh N. Rat fibroblast growth factor receptor-4 mRNA in the brain is preferentially expressed in cholinergic neurons in the medial habenular nucleus. Neurosci Lett 1996, 203:101-104. 10.1016/0304-3940(95)12272-9, 8834103.
8. Wang QP, Guan JL, Pan W, Kastin AJ, Shioda S. A diffusion barrier between the area postrema and nucleus tractus solitarius. Neurochem Res 2008, 33:2035-2043. 10.1007/s11064-008-9676-y, 18373195.
9. Peruzzo B, Pastor FE, Blazquez JL, Schobitz K, Pelaez B, Amat P, Rodriguez EM. A second look at the barriers of the medial basal hypothalamus. Exp Brain Res 2000, 132:10-26. 10.1007/s002219900289, 10836632.
10. Blazquez JL, Rodriguez EM. The design of barriers in the hypothalamus allows the median eminence and the arcuate nucleus to enjoy private milieus: the former opens to the portal blood and the latter to the cerebrospinal fluid. Peptides 2010, 31:757-776. 10.1016/j.peptides.2010.01.003, 20093161.
11. Kastin AJ, Pan W. Blood-brain barrier and feeding: regulatory roles of saturable transport systems for ingestive peptides. Curr Pharm Des 2008, 14:1615-1619. 10.2174/138161208784705423, 2750905, 18673203.
12. Pan W, Kastin AJ. Interactions of cytokines with the blood-brain barrier: implications for feeding. Curr Pharm Des 2003, 9:827-831. 10.2174/1381612033455332, 12678882.
13. Deguchi Y, Naito T, Yuge T, Furukawa A, Yamada S, Pardridge WM, Kimura R. Blood-brain barrier transport of 125I-labeled basic fibroblast growth factor. Pharm Res 2000, 17:63-69. 10.1023/A:1007570509232, 10714610.
14. Hsuchou H, Pan W, Kastin AJ. The fasting polypeptide FGF21 can enter brain from blood. Peptides 2007, 28:2382-2386. 10.1016/j.peptides.2007.10.007, 2151924, 17996984.
15. Gerhard GS, Styer AM, Wood GC, Roesch SL, Petrick AT, Gabrielsen J, Strodel WE, Still CD, Argyropoulos G. A role for fibroblast growth factor 19 and bile acids in diabetes remission after Roux-en-Y gastric bypass. Diabetes Care 2013, 36:1859-1864. 10.2337/dc12-2255, 23801799.
16. Takasato Y, Rapoport SI, Smith QR. An in situ brain perfusion technique to study cerebrovascular transport in the rat. Am J Physiol 1984, 247:H484-H493.
17. Pan W, Banks WA, Kastin AJ. Permeability of the blood-brain barrier to neurotrophins. Brain Res 1998, 788:87-94. 10.1016/S0006-8993(97)01525-4, 9554964.
18. Kastin AJ, Akerstrom V, Pan W. Validity of multiple-time regression analysis in measurement of tritiated and iodinated leptin crossing the blood-brain barrier: meaningful controls. Peptides 2001, 22:2127-2136. 10.1016/S0196-9781(01)00569-1, 11786200.
19. Spranger J, Verma S, Gohring I, Bobbert T, Seifert J, Sindler AL, Pfeiffer A, Hileman SM, Tschop M, Banks WA. Adiponectin does not cross the blood-brain barrier but modifies cytokine expression of brain endothelial cells. Diabetes 2006, 55:141-147. 10.2337/diabetes.55.01.06.db05-1077, 16380487.
20. Kir S, Kliewer SA, Mangelsdorf DJ. Roles of FGF19 in liver metabolism. Cold Spring Harb Symp Quant Biol 2011, 76:139-144. 10.1101/sqb.2011.76.010710, 21813638.
21. Kir S, Beddow SA, Samuel VT, Miller P, Previs SF, Suino-Powell K, Xu HE, Shulman GI, Kliewer SA, Mangelsdorf DJ. FGF19 as a postprandial, insulin-independent activator of hepatic protein and glycogen synthesis. Science 2011, 331:1621-1624. 10.1126/science.1198363, 3076083, 21436455.
22. Wu X, Lemon B, Li X, Gupte J, Weiszmann J, Stevens J, Hawkins N, Shen W, Lindberg R, Chen JL, Tian H, Li Y. C-terminal tail of FGF19 determines its specificity toward Klotho co-receptors. J Biol Chem 2008, 283:33304-33309. 10.1074/jbc.M803319200, 2662259, 18829467.
23. Kurosu H, Kuro O. The Klotho gene family as a regulator of endocrine fibroblast growth factors. Mol Cell Endocrinol 2009, 299:72-78. 10.1016/j.mce.2008.10.052, 19063940.
24. Kuro-o M. Endocrine FGFs and Klothos: emerging concepts. Trends Endocrinol Metab 2008, 19:239-245. 10.1016/j.tem.2008.06.002, 18692401.
25. Wang Y, Sun Z. Current understanding of klotho. Ageing Res Rev 2009, 8:43-51. 10.1016/j.arr.2008.10.002, 2637560, 19022406.
26. Reiche M, Bachmann A, Lossner U, Bluher M, Stumvoll M, Fasshauer M. Fibroblast growth factor 19 serum levels: relation to renal function and metabolic parameters. Horm Metab Res 2010, 42:178-181. 10.1055/s-0029-1243249, 20013647.
27. Potthoff MJ, Kliewer SA, Mangelsdorf DJ. Endocrine fibroblast growth factors 15/19 and 21: from feast to famine. Genes Dev 2012, 26:312-324. 10.1101/gad.184788.111, 3289879, 22302876.
28. Shusta EV, Boado RJ, Mathern GW, Pardridge WM. Vascular genomics of the human brain. J Cereb Blood Flow Metab 2002, 22:245-252.
29. Nishimura T, Utsunomiya Y, Hoshikawa M, Ohuchi H, Itoh N. Structure and expression of a novel human FGF, FGF-19, expressed in the fetal brain. Biochim Biophys Acta 1999, 1444:148-151. 10.1016/S0167-4781(98)00255-3, 9931477.